Repro-Med Dinged With Warning Letter for Quality System, MDR Violations

The GMP Letter
A A
Chester, N.Y.-based Repro-Med, a manufacturer of infusion pumps and intravascular administration sets, has earned an FDA warning letter for failures involving quality systems and medical device reporting, as well as other violations.

To View This Article:

Login

Subscribe To The GMP Letter